Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Semama, D S
Right arrow Articles by Gouyon, J-B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Semama, D S
Right arrow Articles by Gouyon, J-B
Arch Dis Child Fetal Neonatal Ed 2001;84:F44-F46 ( January )

Effects of cisapride on QTc interval in term neonates

D S Semama, S Bernardini, S Louf, B Laurent-Atthalin, J-B Gouyon

Service de Pédiatrie 2, Centre Hospitalier Universitaire, 10 Bd Maréchal de Lattre de Tassigny, 21034 Dijon Cedex, France

Correspondence to: Dr Semama, Service de Pédiatrie 2, Hôpital d'Enfants, Centre Hospitalier Universitaire, 10 Bd Maréchal de Lattre de Tassigny, 21034 Dijon Cedex, France denis.semama{at}libertysurf.fr

Accepted 29 August 2000

BACKGROUND---Cisapride administration for 48 hours has been shown to increase heart rate corrected QT (QTc) interval in preterm neonates. Accumulation of the drug because of liver enzyme immaturity has been suggested to be the reason. If this is correct, a longer survey of QTc interval should disclose an increase even in term neonates.
OBJECTIVE---A prospective survey of the effects of cisapride on QTc interval in term neonates administered cisapride.
SETTING---Neonatal Unit of the University Hospital of Dijon, France.
DESIGN---QTc interval was determined just before and 48 hours, seven days, and 15 days after the start of treatment.
SUBJECTS---Twenty one term newborn infants (mean gestational age 39.3 weeks) given the recommended dose of cisapride (0.2 mg/kg, four times a day).
RESULTS---Administration of cisapride caused a significant increase in QTc interval (p < 0.01). The mean value increased from 0.397 before treatment to 0.418 after 48 hours, 0.431 by day 7, and 0.447 by day 15. A QTc interval exceeding 0.450 was found in six neonates: three at 48 hours, one at day 7, and two at day 15. In two infants, withdrawal of the drug was associated with normalisation of the QTc interval.
CONCLUSIONS---These results support the hypothesis of cisapride accumulation in newborns due to enzymatic immaturity and indicate that QTc interval should be monitored in neonates receiving this drug.


Keywords: heart; cisapride; QT interval; QTc interval; neonate; term


© 2001 by Archives of Disease in Childhood






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health